404 related articles for article (PubMed ID: 20067561)
1. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome.
Cuijpers ML; Raymakers RA; Mackenzie MA; de Witte TJ; Swinkels DW
Br J Haematol; 2010 May; 149(3):322-33. PubMed ID: 20067561
[TBL] [Abstract][Full Text] [Related]
2. Impact of iron overload in myelodysplastic syndromes.
Fenaux P; Rose C
Blood Rev; 2009 Dec; 23 Suppl 1():S15-9. PubMed ID: 20116635
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the understanding of inherited sideroblastic anaemia.
Camaschella C
Br J Haematol; 2008 Oct; 143(1):27-38. PubMed ID: 18637800
[TBL] [Abstract][Full Text] [Related]
4. Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy.
Leitch HA
Leuk Res; 2007 Dec; 31 Suppl 3():S7-9. PubMed ID: 18037416
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in MDS-pathophysiology, diagnosis, and complications.
Gattermann N; Rachmilewitz EA
Ann Hematol; 2011 Jan; 90(1):1-10. PubMed ID: 20938663
[TBL] [Abstract][Full Text] [Related]
6. Controversies surrounding iron chelation therapy for MDS.
Leitch HA
Blood Rev; 2011 Jan; 25(1):17-31. PubMed ID: 21030120
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial iron metabolism and sideroblastic anemia.
Sheftel AD; Richardson DR; Prchal J; Ponka P
Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
[TBL] [Abstract][Full Text] [Related]
8. Iron chelation therapy for patients with myelodysplastic syndrome.
Yeh SP; Yang YS; Yao CY; Peng CT
Hemoglobin; 2009; 33(5):339-45. PubMed ID: 19814680
[TBL] [Abstract][Full Text] [Related]
9. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.
Gattermann N
Leuk Res; 2007 Dec; 31 Suppl 3():S10-5. PubMed ID: 18037413
[TBL] [Abstract][Full Text] [Related]
10. Iron overload in myelodysplastic syndromes: a Canadian consensus guideline.
Wells RA; Leber B; Buckstein R; Lipton JH; Hasegawa W; Grewal K; Yee K; Olney HJ; Larratt L; Vickars L; Tinmouth A
Leuk Res; 2008 Sep; 32(9):1338-53. PubMed ID: 18405971
[TBL] [Abstract][Full Text] [Related]
11. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.
Nearman ZP; Szpurka H; Serio B; Warshawksy I; Theil K; Lichtin A; Sekeres MA; Maciejewski JP
Am J Hematol; 2007 Dec; 82(12):1076-9. PubMed ID: 17654685
[TBL] [Abstract][Full Text] [Related]
12. The deleterious effects of iron overload in patients with myelodysplastic syndromes.
Dreyfus F
Blood Rev; 2008 Dec; 22 Suppl 2():S29-34. PubMed ID: 19059054
[TBL] [Abstract][Full Text] [Related]
13. Iron overload and chelation therapy in myelodysplastic syndromes.
Temraz S; Santini V; Musallam K; Taher A
Crit Rev Oncol Hematol; 2014 Jul; 91(1):64-73. PubMed ID: 24529413
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.
Malcovati L
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S305-11. PubMed ID: 19778858
[TBL] [Abstract][Full Text] [Related]
15. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
[TBL] [Abstract][Full Text] [Related]
16. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes.
Malcovati L
Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415
[TBL] [Abstract][Full Text] [Related]
17. Iron chelation therapy in MDS: what have we learnt recently?
Schmid M
Blood Rev; 2009 Dec; 23 Suppl 1():S21-5. PubMed ID: 20116636
[TBL] [Abstract][Full Text] [Related]
18. Approach to anemia associated with myelodysplastic syndromes.
Hellström-Lindberg E
Curr Hematol Rep; 2003 Mar; 2(2):122-9. PubMed ID: 12901143
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
Jabbour E; Kantarjian HM; Koller C; Taher A
Cancer; 2008 Mar; 112(5):1089-95. PubMed ID: 18186499
[TBL] [Abstract][Full Text] [Related]
20. Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines.
Mittelman M; Lugassy G; Merkel D; Tamary H; Sarid N; Rachmilewitz E; Hershko C; ;
Isr Med Assoc J; 2008 May; 10(5):374-6. PubMed ID: 18605364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
